[1] |
Kwon T, Lamster IB, Levin L. Current concepts in the management of periodontitis[J]. Int Dent J, 2021, 71(6): 462-476.
doi: 10.1111/idj.12630
pmid: 34839889
|
[2] |
Hajishengallis G. Periodontitis: From microbial immune subversion to systemic inflammation[J]. Nat Rev Immunol, 2015, 15(1): 30-44.
doi: 10.1038/nri3785
pmid: 25534621
|
[3] |
Massaccesi L, Galliera E, Pellegrini A, et al. Osteomyelitis, oxidative stress and related biomarkers[J]. Antioxidants, 2022, 11(6): 1061.
|
[4] |
Kikuta J, Ishii M. Osteoclast migration, differentiation and function: Novel therapeutic targets for rheumatic diseases[J]. Rheumatology, 2013, 52(2): 226-234.
doi: 10.1093/rheumatology/kes259
pmid: 23024017
|
[5] |
Liu YH, Wang C, Wang G, et al. Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities[J]. Theranostics, 2019, 9(16): 4648-4662.
doi: 10.7150/thno.35414
pmid: 31367247
|
[6] |
Simpson BW, Trent MS. Pushing the envelope: LPS modifications and their consequences[J]. Nat Rev Microbiol, 2019, 17(7): 403-416.
doi: 10.1038/s41579-019-0201-x
pmid: 31142822
|
[7] |
Dahariya S, Paddibhatla I, Kumar S, et al. Long non-coding RNA: Classification, biogenesis and functions in blood cells[J]. Mol Immunol, 2019, 112: 82-92.
doi: S0161-5890(19)30061-6
pmid: 31079005
|
[8] |
Atianand MK, Hu WQ, Satpathy AT, et al. A long noncoding RNA lincRNA-EPS acts as a transcriptional brake to restrain inflammation[J]. Cell, 2016, 165(7): 1672-1685.
doi: S0092-8674(16)30722-X
pmid: 27315481
|
[9] |
Zhang BP, Li Q, Jia SW, et al. LincRNA-EPS in biomimetic vesicles targeting cerebral infarction promotes inflammatory resolution and neurogenesis[J]. J Transl Med, 2020, 18(1): 110.
doi: 10.1186/s12967-020-02278-z
pmid: 32122362
|
[10] |
Li YB, Xi ZW, Yu Z, et al. LincRNA-EPS increases TGF-β expression to inhibit the Wnt/β-catenin pathway, VSMC osteoblastic differentiation and vascular calcification in diabetic mice[J]. Exp Ther Med, 2022, 23(6): 425.
doi: 10.3892/etm.2022.11352
pmid: 35607373
|
[11] |
Kim JM, Lin CJ, Stavre Z, et al. Osteoblast-osteoclast communication and bone homeostasis[J]. Cells, 2020, 9(9): 2073.
|
[12] |
Souza PPC, Lerner UH. Finding a toll on the route: The fate of osteoclast progenitors after toll-like receptor activation[J]. Front Immunol, 2019, 10: 1663.
doi: 10.3389/fimmu.2019.01663
pmid: 31379855
|
[13] |
Xiao Y, Cao Y, Song CC, et al. Cellular study of the LPS-induced osteoclastic multinucleated cell formation from RAW264.7 cells[J]. J Cell Physiol, 2020, 235(1): 421-428.
doi: 10.1002/jcp.28982
pmid: 31222739
|
[14] |
Darby I. Risk factors for periodontitis & peri-implantitis[J]. Periodontol 2000, 2022, 90(1): 9-12.
doi: 10.1111/prd.12447
pmid: 35913624
|
[15] |
Dym H, Zeidan J. Microbiology of acute and chronic osteomyelitis and antibiotic treatment[J]. Dent Clin North Am, 2017, 61(2): 271-282.
doi: S0011-8532(16)30135-5
pmid: 28317566
|
[16] |
Bhattarai G, Poudel SB, Kook SH, et al. Resveratrol prevents alveolar bone loss in an experimental rat model of periodontitis[J]. Acta Biomater, 2016, 29: 398-408.
doi: S1742-7061(15)30161-6
pmid: 26497626
|
[17] |
Zeng XZ, Zhang YY, Yang Q, et al. Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4/TRAF6 and PLCγ1-Ca2+-NFATc1 signaling pathway[J]. Acta Pharmacol Sin, 2020, 41(2): 229-236.
|
[18] |
Sun XY, Zhang J, Wang ZJ, et al. Licorice isoliquiritigenin-encapsulated mesoporous silica nanoparticles for osteoclast inhibition and bone loss prevention[J]. Theranostics, 2019, 9(18): 5183-5199.
doi: 10.7150/thno.33376
pmid: 31410209
|
[19] |
Udagawa N, Koide M, Nakamura M, et al. Osteoclast differentiation by RANKL and OPG signaling pathways[J]. J Bone Miner Metab, 2021, 39(1): 19-26.
doi: 10.1007/s00774-020-01162-6
pmid: 33079279
|
[20] |
Liu JZ, Wang SQ, Zhang P, et al. Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis[J]. J Biol Chem, 2009, 284(18): 12512-12523.
doi: 10.1074/jbc.M809789200
pmid: 19258321
|
[21] |
Yin YF, Yan PX, Lu JL, et al. Opposing roles for the lncRNA haunt and its genomic locus in regulating HOXA gene activation during embryonic stem cell differentiation[J]. Cell Stem Cell, 2015, 16(5): 504-516.
doi: 10.1016/j.stem.2015.03.007
pmid: 25891907
|
[22] |
Ulitsky I, Bartel DP. lincRNAs: Genomics, evolution, and mechanisms[J]. Cell, 2013, 154(1): 26-46.
doi: 10.1016/j.cell.2013.06.020
pmid: 23827673
|
[23] |
Nojima T, Proudfoot NJ. Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics[J]. Nat Rev Mol Cell Biol, 2022, 23(6): 389-406.
|
[24] |
Zhang RL, Li JH, Li GC, et al. LncRNA Nron regulates osteoclastogenesis during orthodontic bone resorption[J]. Int J Oral Sci, 2020, 12(1): 14.
doi: 10.1038/s41368-020-0077-7
pmid: 32385254
|
[25] |
Liu C, Cao Z, Bai Y, et al. LncRNA AK077216 promotes RANKL-induced osteoclastogenesis and bone resorption via NFATc1 by inhibition of NIP45[J]. J Cell Physiol, 2019, 234(2): 1606-1617.
doi: 10.1002/jcp.27031
pmid: 30132869
|